Literature DB >> 32032282

Accelerating availability of clinically-relevant parameter estimates from thromboelastogram point-of-care device.

Michelle A Pressly1, Robert S Parker, Matthew D Neal, Jason L Sperry, Gilles Clermont.   

Abstract

BACKGROUND: Modeling approaches offer a novel way to detect and predict coagulopathy in trauma patients. A dynamic model, built and tested on thromboelastogram (TEG) data, was used to generate a virtual library of over 160,000 simulated RapidTEGs. The patient-specific parameters are the initial platelet count, platelet activation rate, thrombus growth rate, and lysis rate (P(0), k1, k2, and k3, respectively).
METHODS: Patient data from both STAAMP (n = 182 patients) and PAMPer (n = 111 patients) clinical trials were collected. A total of 873 RapidTEGs were analyzed. One hundred sixteen TEGs indicated maximum amplitude (MA) below normal and 466 TEGs indicated lysis percent above normal. Each patient's TEG response was compared against the virtual library of TEGs to determine library trajectories having the least sum-of-squared error versus the patient TEG up to each specified evaluation time ∈ (3, 4, 5, 7.5, 10, 15, 20 minutes). Using 10 nearest-neighbor trajectories, a logistic regression was performed to predict if the patient TEG indicated MA below normal (<50 mm), lysis percent 30 minutes after MA (LY30) greater than 3%, and/or blood transfusion need using the parameters from the dynamic model.
RESULTS: The algorithm predicts abnormal MA values using the initial 3 minutes of RapidTEG data with a median area under the curve of 0.95, and improves with more data to 0.98 by 10 minutes. Prediction of future platelet and packed red blood cell transfusion based on parameters at 4 and 5 minutes, respectively, provides equivalent predictions to the traditional TEG parameters in significantly less time. Dynamic model parameters could not predict abnormal LY30 or future fresh-frozen plasma transfusion.
CONCLUSION: This analysis could be incorporated into TEG software and workflow to quickly estimate if the MA would be below or above threshold value within the initial minutes following a TEG, along with an estimate of what blood products to have on hand. LEVEL OF EVIDENCE: Therapeutic/Care Management: Level IV.

Entities:  

Mesh:

Year:  2020        PMID: 32032282      PMCID: PMC7887698          DOI: 10.1097/TA.0000000000002608

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  16 in total

1.  A multiscale model of venous thrombus formation with surface-mediated control of blood coagulation cascade.

Authors:  Zhiliang Xu; Joshua Lioi; Jian Mu; Malgorzata M Kamocka; Xiaomin Liu; Danny Z Chen; Elliot D Rosen; Mark Alber
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 2.  Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*.

Authors: 
Journal:  Anesthesiology       Date:  2015-02       Impact factor: 7.892

3.  Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients.

Authors:  Marc Maegele; Rolf Lefering; Nedim Yucel; Thorsten Tjardes; Dieter Rixen; Thomas Paffrath; Christian Simanski; Edmund Neugebauer; Bertil Bouillon
Journal:  Injury       Date:  2007-01-09       Impact factor: 2.586

4.  A model for the tissue factor pathway to thrombin. II. A mathematical simulation.

Authors:  K C Jones; K G Mann
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

5.  A model for the stoichiometric regulation of blood coagulation.

Authors:  Matthew F Hockin; Kenneth C Jones; Stephen J Everse; Kenneth G Mann
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

6.  Thrombelastography and rotational thromboelastometry early amplitudes in 182 trauma patients with clinical suspicion of severe injury.

Authors:  Anna Sina P Meyer; Martin A S Meyer; Anne Marie Sørensen; Lars S Rasmussen; Morten B Hansen; John B Holcomb; Bryan A Cotton; Charles E Wade; Sisse R Ostrowski; Pär I Johansson
Journal:  J Trauma Acute Care Surg       Date:  2014-03       Impact factor: 3.313

7.  Modelling fibrinolysis: a 3D stochastic multiscale model.

Authors:  Brittany E Bannish; James P Keener; Aaron L Fogelson
Journal:  Math Med Biol       Date:  2012-12-04       Impact factor: 1.854

8.  Thrombelastography early amplitudes in bleeding and coagulopathic trauma patients: Results from a multicenter study.

Authors:  Thomas H Laursen; Martin A S Meyer; Anna Sina P Meyer; Tina Gaarder; Paal A Naess; Jakob Stensballe; Sisse R Ostrowski; Pär I Johansson
Journal:  J Trauma Acute Care Surg       Date:  2018-02       Impact factor: 3.313

9.  Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage.

Authors:  S Mallaiah; P Barclay; I Harrod; C Chevannes; A Bhalla
Journal:  Anaesthesia       Date:  2014-10-07       Impact factor: 6.955

10.  Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) Trial: Addressing the Knowledge Gaps.

Authors:  Joshua B Brown; Matthew D Neal; Francis X Guyette; Andrew B Peitzman; Timothy R Billiar; Brian S Zuckerbraun; Jason L Sperry
Journal:  Prehosp Emerg Care       Date:  2014-07-30       Impact factor: 3.077

View more
  3 in total

1.  Personalized modulation of coagulation factors using a thrombin dynamics model to treat trauma-induced coagulopathy.

Authors:  Damon E Ghetmiri; Mitchell J Cohen; Amor A Menezes
Journal:  NPJ Syst Biol Appl       Date:  2021-12-07

Review 2.  What's new in trauma 2020.

Authors:  Wen-Jun Zhao; Gui-E Liu; Yuan Tian; Shuang-Ming Song; Lei Li
Journal:  Chin J Traumatol       Date:  2021-02-01

Review 3.  Hemorrhagic Resuscitation Guided by Viscoelastography in Far-Forward Combat and Austere Civilian Environments: Goal-Directed Whole-Blood and Blood-Component Therapy Far from the Trauma Center.

Authors:  James H Lantry; Phillip Mason; Matthew G Logsdon; Connor M Bunch; Ethan E Peck; Ernest E Moore; Hunter B Moore; Matthew D Neal; Scott G Thomas; Rashid Z Khan; Laura Gillespie; Charles Florance; Josh Korzan; Fletcher R Preuss; Dan Mason; Tarek Saleh; Mathew K Marsee; Stefani Vande Lune; Qamarnisa Ayoub; Dietmar Fries; Mark M Walsh
Journal:  J Clin Med       Date:  2022-01-12       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.